跳转到主要内容
搜索
Site Search
Mainland China
|
zh
Choose Location
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Brazil |
Português
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Mexico |
Español
(link is external)
United States |
English
(link is external)
Australia |
English
(link is external)
Bangladesh |
English
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Mainland China |
中文
Malaysia |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Singapore |
English
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Austria |
Deutsch
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Bulgaria |
Български
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hungary |
Magyar
(link is external)
Ireland |
English
(link is external)
Italy |
Italiano
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Serbia |
Srpski
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Turkey |
Türk
(link is external)
United Kingdom |
English
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Egypt |
English
(link is external)
Israel |
עברית
(link is external)
Saudi Arabia |
العربية
(link is external)
South Africa |
English
(link is external)
cn
Choose Location
asia-pacific
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Australia |
English
(link is external)
Austria |
Deutsch
(link is external)
Bangladesh |
English
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Brazil |
Português
(link is external)
Bulgaria |
Български
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Egypt |
English
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
Hungary |
Magyar
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Ireland |
English
(link is external)
Israel |
עברית
(link is external)
Italy |
Italiano
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Mainland China |
中文
Malaysia |
English
(link is external)
Mexico |
Español
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Saudi Arabia |
العربية
(link is external)
Serbia |
Srpski
(link is external)
Singapore |
English
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
South Africa |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Turkey |
Türk
(link is external)
United Kingdom |
English
(link is external)
United States |
English
(link is external)
菜单
关于诺华
战略
多元、平等与包容
员工和文化
我们的价值观
我们的领导层
诺华中国管理团队
联系我们
关于诺华
患者与照护者
诺华对患者和照护者的承诺
疾病领域
临床试验
患者与照护者
诺华在中国
概览
企业责任
诺华大事记
诺华中国业务
诺华中国荣誉
诺华在中国
环境、社会和治理
道德、风险和合规
可及性
环境可持续发展
全球健康
道德行为
环境、社会和治理
新闻中心
新闻发布
专题故事
媒体联络
新闻中心
职业发展
职位搜索
人才发展
员工福利
全球荣誉
(link is external)
职业发展
首页
页眉
诺华上海园区
扎根中国，承诺中华
主页
新闻中心
新闻发布
新闻发布
Date Range
- 任意 -
In The News
Media Release
Featured News
Story
News Type Filters
Language
- 任意 -
English
French
German
开始日期
结束日期
News Archive Navigation
News Archive Navigation
全部
Show More Links
新闻发布
专题故事
icon
列表视图
Showing 250 results
6月 2022
Featured News
6月 28, 2022
诺华Tabrecta®获欧盟委员会批准 用于治疗METex14跳跃突变晚期非小细胞肺癌
Featured News
6月 24, 2022
诺华达拉非尼联合曲美替尼方案获FDA批准成为首个用于BRAF V600E突变泛瘤种治疗药物组合
Featured News
6月 13, 2022
2022 ASCO速递：诺华公布达拉非尼联合曲美替尼在BRAF V600儿童低级别脑胶质瘤患者研究的创新成绩
Featured News
6月 08, 2022
2022 ASCO速递——Ribociclib带给乳腺癌患者的总生存获益再添新证
五月 2022
Featured News
5月 31, 2022
诺华于2022 ASCO和EHA发表乳腺癌和前列腺癌最新研究和创新成果
Featured News
5月 24, 2022
诺华突破性降脂创新药Inclisiran疾速落地粤港澳大湾区
Featured News
5月 20, 2022
瑞弗兰®（艾曲泊帕乙醇胺片）治疗6-11岁儿童慢性免疫性（特发性）血小板减少症*在华获批
Featured News
5月 17, 2022
诺华创新药物诺欣妥®（沙库巴曲缬沙坦）荣获国际盖伦奖最佳医药产品奖
4月 2022
Story
4月 30, 2022
药物
先发制“虫”，力争彻底消灭疟疾
Thierry Diagana携手团队，潜心钻研抗疟新疗法。他坚信人类能够消灭疟疾，但疟原虫表现出的耐药性日益显著，这可能危及来之不易的胜利果实。
Story
4月 15, 2022
药物
应对气候变化造成的健康损害
Featured News
4月 14, 2022
诺华茁乐®（奥马珠单抗）慢性自发性荨麻疹适应症在华获批
3月 2022
Featured News
3月 28, 2022
诺华眼底病创新药布西珠单抗在粤港澳大湾区完成首针注射，眼底病患者迎来新希望
分页
‹
前一页
1
…
6
7
8
9
10
11
12
…
21
›
下一页
All
Last 7 Days
Last 30 Days
Last 6 months
自定义
Cancel
Apply
